Genipin derivative and application thereof
A derivative, genipin technology, applied in the field of preparation of new compounds
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0133] The synthesis of embodiment 1 genipin derivative
[0134] 1.1 Instruments and reagents
[0135] Nuclear magnetic resonance spectrum adopts Brucker 400MHz ADVANCE DMX 500 type nuclear magnetic resonance instrument to measure (TMS is internal standard, CDC1 3 is solvent); mass spectrum adopts Esquire 600 (Germany Brucker) mass spectrometer to measure (ESI-MS);
[0136] Genipin was purchased from Linchuan Zhixin Biotechnology Co., Ltd.; the silica gel was 200-300 mesh (Qingdao Ocean Chemical Factory), and other reagents were domestic analytical reagents without further purification before use.
[0137] 1.2 Synthesis of intermediates
[0138] Synthesis of Intermediate 1: Add genipin (5g, 22.1mmol), methanol (100mL), and boron trifluoride ether (500mg) into a 500mL single-necked bottle, stir at room temperature for 24h, and monitor by TLC. After the reaction is complete, add saturated Sodium bicarbonate quenched the reaction, removed most of the methanol under reduced pre...
Embodiment 2
[0171] Example 2 Detection of anti-diabetic biological activity of genipin derivatives
[0172] The peroxisome proliferator-activated receptor gamma subtype is a fatty acid receptor that plays a key role in energy metabolism. Dysfunction of the peroxisome proliferator-activated receptor gamma subtype is associated with diabetes, cardiovascular disease, and obesity, and this receptor is therefore an important target for the development of drugs for type II diabetes. However, the experimental data show that the compound of the present application has no activating effect on the peroxisome proliferator-activated receptor gamma subtype.
[0173] Dipeptidyl peptidase IV inhibitors are new hypoglycemic drugs that have attracted much attention at present. Studies have shown that dipeptidyl peptidase IV inhibitors can promote the release of insulin from β cells, increase the synthesis of insulin in β cells, and inhibit the secretion of glucagon at the same time, without hypoglycemia ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com